MEDX Ventures Group is different. Focused on value creation for our portfolio companies, we are a med-tech investment and management firm. We utilize our team of accomplished professionals from diverse disciplines to provide hands-on continual support to our portfolio companies. We have a proven track record of creating and nurturing successful Israeli med-tech companies. We are here to help you achieve your goals.
MEDX Ventures Group, founded in 2010, is an investment and management company with offices in Israel, USA and Europe. The company believes in active management (as opposed to passive investment), and is focusing on medical ventures and technologies in Israel while utilizing the Company’s unique X Model to include its core Development, Regulatory, Commercial and Finance team that manages a portfolio of ventures.
MEDX Ventures Group capitalizes on its global presence while utilizing Israel’s unique research, development and operations capabilities in the field; As such the company focuses on smart investment, reduced risk, short time to market and efficient return on investment.
MEDX Ventures Group is led by highly experienced medical device management and investment team from different aspects of the business to ensure the Company’s X Model is fully implemented and executed in each of its activities and ventures. In addition, the company continuously seeks alliances with global industry leaders, beginning in project development stage, to ensure medical innovations become the life changing reality for patients and providers, while becoming a profitable business to all stakeholders and generating attractive return for investors.
Harel is a seasoned executive and entrepreneur in the healthcare space, where he has an extensive and proven track record for over 15 years of leadership positions in the corporate world as well as the start-up sector, including USA, Europe and Israel. In 2010, Harel founded MEDX Ventures Group LLC, an investment and management firm with offices in the USA, Europe and Israel. Harel serves as the CEO & Chairman of Microbot Medical Ltd., a promising early stage medical device company. In addition, Harel serves as the Executive Chairman of XACT Robotics Ltd., another transformational, early stage medical device company, where MEDX is the leading investor. Until 2013, Harel also served on the board of directors at ConTIPI Ltd., which was acquired during his tenure by Kimberly-Clark Corporation.
Before founding MEDX Ventures Group, Harel served as a Worldwide Group Marketing Director at Johnson & Johnson (Ethicon Inc., Somerville NJ), overseeing the company’s global strategic marketing. Prior to this, Harel was the Regional Marketing Manager at Johnson & Johnson (Ethicon Inc.), responsible for the strategic marketing for Europe, Middle East and Africa. During his tenure, Harel led both companies to continuous growth in revenues and new product launches (both from internal R&D and M&A). Harel also held several management positions in marketing and sales at Johnson & Johnson Medical Israel.
Harel is a guest speaker for management and innovation courses at leading universities in the USA and Israel, including the Technion – Israel Institute of Technology. Harel holds a Bachelor of Science (BS) from Siena College (USA) and a Master in Business Administration (MBA) from Manchester University (UK).
Simon brings almost three decades of proven leadership and experience in operations, research and development, focusing mainly on medical devices. Currently,
Simon serves as the Chief Operating Officer at Microbot Medical Ltd, an early stage company developing a platform of micro-robots for various medical applications and as a Scientific Director at XACT Robotics Ltd.
Prior to joining Microbot and XACT, Simon was the VP Research & Development at IceCure Medical Ltd., a TASE traded company developing a portfolio of cryogenic ablation systems. Before his experience with IceCure, Simon served as the CEO and VP Research & Development of Anorad Israel (a business unit of Rockwell Automation).
Prior to Anorad, Simon was the Research & Development Manager at Disc-O-Tech Medical Technologies Ltd., a successful orthopedic venture that was acquired by Kyphon (currently part of Medtronic), and before this as the Research & Development Manager at CI Systems.
Simon holds a BSc. In Mechanical Engineering from the Technion – Israel Institute of Technology, a MSc. in Mechanical Engineering from MIT where he specialized in motion control and robotics, and a MBA from the Kellogg-Recanati School of Management.
Ahava is a leading expert in regulatory affairs, clinical and quality assurance (QA) specializing in FDA and CE submissions as well as documentation for medical devices with over 20 years of experience working directly with the FDA. Her regulatory experience includes all types of regulatory submissions, including 510(k), PMA, IDE, Pre-IDE, 513(g), and RFD, for a wide variety of innovative, medical devices and includes participation in PMA Panel meetings. Ahava has managed many multicenter, clinical studies conducted around the world, and as part of the regulatory clearance/approval process participated in numerous BIMO inspections, including clinical site inspections in the US, Europe and Israel as well as Sponsor inspections. Additionally, Ahava has extensive experience in implementing QA systems at medical device companies, submitting PMA manufacturing sections and participating in a multitude of QSR and ISO 13485 inspections by the FDA and European Notified Bodies. Ahava has a Biology degree (BSc) from Bar-Ilan University and completed 3 years of medical school at the Technion Institute.
Nadav is a seasoned corporate and transactional lawyer with extensive experience in structuring, negotiating and documenting complex collaboration and co-development transactions, IP licensing and technology transfer transactions and other commercial and corporate finance transactions. With ten years’ experience as general counsel and/or as a senior executive in technology companies and technology licensing arms of academic institutions, Nadav brings a wealth of business experience to structuring transactions and a unique business perspective to solving legal issues.
Until 2011, Nadav was a partner at Yigal Arnon & Co., where he headed the IP Transactions Group. Prior to joining Yigal Arnon in August 2009, Nadav served for four years as Director of Technology Transactions at Harvard University’s Office of Technology Development, where he formed and headed an “in-house” transactional legal team, responsible for strategy, structuring, negotiation and drafting of all of Harvard’s technology related agreements.
Prior to his position at Harvard, Nadav served as Vice President and General Counsel of Ramot at Tel Aviv University Ltd., the technology transfer company of Tel Aviv University.Before joining Ramot, he was Vice President and General Counsel of Compugen Ltd. (CGEN: NASDAQ).
Prior to joining Compugen, Nadav was an associate at Yigal Arnon & Co.
Nadav holds a JD and a BA in Middle Eastern Studies from the University of California, Berkeley.
Maryana brings over 10 years of excellence in analytics, business development as well as project management in the life science space.
Prior to joining the team, Maryana was an independent due-diligence consultant to Plus Venture Investments, Yozmot-HaEmek Incubator, Tamir Fishman Investment Bank as well as private investors.
Formerly, Maryana was associate in the life science sector at Roberts Mitani LLC, a NY based investment bank. Prior to this, Maryana held positions as a study director at DelaPharm Ltd., a project consultant for the Israel Institute of Technology (Technion), a project manager at PharmaSeed Ltd. and a market researcher at Vital Medical Ltd.
Maryana spent over 7 years in leading research groups at the Technion and Bar-Ilan University, and her research was published in several scientific journals.
Maryana holds a B.Sc, a M.Sc. and a PhD from the Faculty of Life Science at Bar-Ilan University.
Danna brings nearly 7 years of experience in IP strategy and development in the medical devices field.
Prior to joining MEDX, Danna was a leading member and played a key role at the in-house IP team at Medingo Ltd., a medical device company which was acquired by Roche in 2010. During her tenure at Medingo, Danna successfully managed numerous patent applications throughout their entire life cycle, from draft to grant, including active management of patent prosecution processes in various countries worldwide, as well as playing a key role in several complex Freedom-to-Operate analyses.
Prior to Medingo, Danna was an associate at Lavie, Michlin & Co., where she specialized in tort law. Danna serves on the Board of Directors of Prize4Life, a nonprofit organization dedicated to accelerating the discovery of treatments and a cure for ALS.
Danna holds an LL.B. and a B.A. in Economics, both from the University of Haifa, and has completed over two year of studies at the Biomedical Engineering department of the Technion – Israel Institute of Technology.
Steve has been a leader in the medical device field in Israel and Europe for over 20 years. Steve has extensive experience and a proven track record in the Orthopedics (Joints, Trauma etc.), Spine and Neurosurgical fields. As a leader in his space, Steve excelled in new product introductions to different geographical markets through focus on market development. Steve continuously led his organizations to deliver top and bottom lines, increasing revenues, operational processes, integrating new business and improving business practices.
Most recently Steve was the founder and General Manager of Globus Medical Israel Ltd., leading the introduction of the company into the Israeli market while establishing a strong business presence. Prior to this, Steve was the Spine and Navigation Business Manager and a Board Member at Medtronic Israel Ltd., leading the business units in both Israel and in the Baltic region. Before his position with Medtronic, Steve enjoyed a successful tenure as a Sales Manager at Johnson & Johnson Medical Israel, establishing, growing and sustaining the company’s leadership position in the orthopedic space in Israel.
With his unique knowledge and experience in the Orthopedics (Joints, Trauma etc.), Spine and Neurosurgical fields, Steve also serves as an industry expert for multiple Israeli startups at different stages of development.
Eric C. Leuthardt, M.D. is a neurosurgeon who is currently an associate professor with the Department of Neurological Surgery, and the Departments of Neurobiology, Biomedical Engineering, Mechanical Engineering and Material Sciences at Washington University in St. Louis. He is Director of the Center for Innovation in Neuroscience and Technology and the Brain Laser Center.
He received his B.S. in Biology and Theology at St. Louis University in 1995 and received his M.D. at the University of Pennsylvania’s School of Medicine in 1999. He went on to complete his training at Barnes Jewish Hospital and Washington University in St. Louis in 2005 and then completed a combined fellowship in epilepsy and spinal surgery at the University of Washington in Seattle in 2006. His research has focused on neuroprosthetics – devices linked to the brain that may restore function to patients with motor disabilities. His work in the field of neuroprosthetics and neurosurgical devices has yielded him numerous accolades as a scientist, a neurosurgeon, and an inventor.
Dr. Leuthardt uses an integrated approach by employing multiple domains of expertise ranging from biomedical engineering, clinical neurosurgery, mathematical modeling, complex signal analysis, and computer programming. In addition to numerous peer-reviewed publications, Leuthardt has over 1400 patents on file with the U.S. Patent and Trademark Office for medical devices and brain computer interface technologies. He is also the founder of five startup companies.
Dr. Bomback has excelled throughout his entire academic career. He graduated cum laude from Columbia College, Columbia University where he was named one of only five Rabi Scholars (for mathematics and science) in his class. He then earned his medical degree at Columbia College of Physicians & Surgeons, Columbia University, once again graduating at the top of his class with honors. He was named to the Alpha Omega Alpha Society and earned numerous accolades including the Bertsch Prize and Cummins awards for most promising surgeon. He then completed his internship and residency in Orthopaedic Surgery at Yale New Haven Hospital, and ultimately served as Chief Resident there as well. His professionalism and spinal research earned him the top two graduating awards (Southwick and Chrisman Awards) in addition to a national Orthopaedic Research and Education Foundation Prize.
Dr. Bomback then completed a Spine and Scoliosis Fellowship at the world-renowned Hospital for Special Surgery (New York, NY) studying all aspects of spinal care including both pediatric and adult. He practices in southwestern Connecticut at the state- and nationally- recognized CT Neck & Back, Specialists, LLC. He devotes his entire practice to spine care – both surgical and nonsurgical. He treats all spinal conditions including complex spinal deformities (scoliosis and kyphosis) as well revision spinal fusions. In addition, he performs a vast amount of minimally invasive spinal procedures, reducing pain and hospital stay. He serves on the Professional Practice Evaluation Committee for Western CT Health Network as the sole surgeon representative, reviewing all cases with significant complications (giving him a particular expertise in second opinions and recognition regarding surgical appropriateness.) He also leads as the Medical Director of the Orthopaedic Surgery/Neurosurgery Unit at Western Connecticut Health Network.
Dr. Bomback has published original research in the top spine publications (Spine, The Spine Journal) and has written numerous articles/chapters relevant to his expertise. He has lectured both nationally and internationally on spinal fusion surgery. Reader’s Digest featured him for his “miracle of surgery”. He has consistently been named a Top Doctor by U.S. News & World Report, a CT Top Doc, Americas Top Orthopaedist, as well as Castle Connolly Top Doctor for Orthopaedics.
Dr. Jacob (Kobi) Cohen is a renowned womens’ health specialist, and Medical Director and co-founder of Aya Medical Center, Campus Assuta Medical Center, the first center for Womans’ gender medicine which offers total medical care to Women.
He graduated Magna Cum Laude in Medicine from Tel Aviv University in 1982.During his many years of experience he has held the post of Head of Ambulatory Outpatient Clinic and Head of Endoscopic (Hysteroscopic) Services at Lis Maternity Hospital, Sourasky Medical Center ,Tel Aviv. He was also for many years Senior Physician, department of Obstetrics and Gynocology, Serlin Maternity Hospital, Sourasky Medical Center, Tel Aviv, Israel.
Jacob conducted his fellowship studies in the advanced study of Minimally-Invasive Surgery under Dr. A.Magos of the Royal Free Hospital in Hampstead, London, UK and in Endoscopy under Professor Rafael F. Valle at the North Western University Medical School, Chicago, USA. He also did fellowship studies in Fertility Endocrinology under Professor B.Lonenfeld at the Institite of Endocinology, Sheba Medical Center, Tel Hashomer, Israel, and Diagnostic and Operative Hysteroscopy under Professor S.Baroux, Tenon Hospital, Paris, France.
His research fellowship topic was Recurring Miscarriages under Professor Y. Shoenfeld at the Research Unit of Autoimmune Diseases, Chaim Sheba Medical Center, Tel Hashomer, Israel. He also participated in a clinical fellowship in Ultrasound under Professor Meisner at Soroka Medical Center,Beer Sheva,Israel and In Vitro Fertilization at Serlin Maternity Hospital at Sourasky Medical Center, Tel Aviv, Israel.
Jacob is also the CMO and Co-founder of Fibro Control’s innovative technology for the treatment of uterine tumors.He is involved in the development,advisory, management and progress of clinical trials.
For the last 30 years he has been a member of the Israel Medical Association. Since then he has become a member of countless renowned associations at home and Internationally. He has also served for many years on the International Advisory Board of the American Association of Gynecological Laparoscopy, and as a reviewer of its journal. He also serves on the board of the Israeli Society of Endoscopy.
Throughout his career he has written and published numerous peer reviewed articles and presented at conferences at home and Internationally. He has also been a regular contributor of articles on all matters of womans‘ health in Womans’ magazines, on line health forums, and on medical magazine programmes on Television.
Prof. Menahem Neuman, specializes in Gynecology, pelvic floor relaxation and pelvic organ prolapse medicine, female urinary incontinence and pelvic floor prolapse surgery.
In addition to his position at the Galilee M.C. Prof. Neuman teaches at the Bar-Ilan University Faculty of Medicine – Safed, Israel, and mentors fellow surgeons from Israel as well as over-seas countries, with the newest surgical methods. Prof. Neuman served J&J Ethicon as a surgical consultant and mentor across Europe, South Africa and was a member of their innovation council for years.
Prof. Neuman is a fellow of the International Urogynecology Association, the International Society of Pelviperineology, the Israeli Society of Pelvic Floor Medicine (and was the secretary of this organization lately). He is a member of editorial boards of the International Urogynecology Journal and of the Pelviperineology. To his credit, Prof. Neuman was developing the newly designed mini-mesh sling at Serag –Wiessner, Naila, Germany. He is the medical director of POP Medical Solutions – a medical devices start-up company, and consultant for Memic (a robotic medical start-up company) and for Bluewind – a magnetic therapy start-up company. Prof. Neuman is world-wide well known for his expertise in female pelvic floor reconstructive procedures.
Prof. Neuman’s research interests are primarily devoted to female urology and pelvic floor medicine. He is the author and coauthor of about 100articles on these and related topics, which are published in prestigious, peer-reviewed scientific journals such as Journal of Urology, European Journal of Urology, European Journal of Obstetrics and Gynecology, Neurourology and Urodynamics, Int. Urogynecology Journal and many others. Prof. Neuman has organized international scientific meetings and delivered local, regional, national, and international invited presentations in his field. He has been Principal Investigator for more than 60 clinical research studies.
Dr. Macomber is a general surgeon and medical technology entrepreneur with a background in medical device development and health information technology. He is the Founder and Chief Medical Officer of UV Therapeutics, a med tech company developing a device based approach for system immune modulation and is currently conducting it’s first human clinical trial for the treatment of Lupus.
Chris recently co-founded a mobile EMR integration platform for providers, Mozaic Medical, that will be launching it’s first platform in 2015. He is the co-founder and assistant director of the Surgical Technology Innovation and Commercialization program at UMass (STIC-UM) and co-founder of the Institute for Inflammatory Disease (INSIDE) at the University Hospitals Coventry and Warwickshire NHS Trust. He also performs medical technology consulting for industry companies.
Chris received a Bachelors of Science in Biology and Music from Union College in 2005, an MBA in Health Care Management from the Graduate College of Union University in 2006 and an MD with Distinction in Health Management Systems from Albany Medical College in 2009, as part of the Eight-Year Leadership in Medicine BS/MBA/MD program. He also completed a two-year research fellowship in surgical outcomes and surgical technology innovation and attended the Program in Clinical Effectiveness at the Harvard School of Public Health in 2011. Concurrently with his role at UVT, Chris is completing his last year of general and laparoscopic surgery as Chief Resident at the University of Massachusetts Medical School. He is a member of the Alpha Omega Alpha Honor Medical Society and the Gold Humanism Honor Society.
Dr. Igal Zuravicky is currently practicing cardiology and lipidology in Albany N.Y. He is board certified in Internal Medicine, Cardiovascular diseases, and Lipidology.
He received his B.S. in Biology at Columbia University, NYC, NY in 1970 and received his M.D. at the University of Lausanne School of Medicine, Lausanne, Switzerland, in 1976. He completed his residency in internal medicine at Norwalk Hospital in Norwalk Ct. and his fellowship in cardiovascular diseases at the Upstate Medical Center in Syracuse, NY.
Dr. Zuravicky has greater than 30 years’ experience in invasive and non-invasive cardiology. He has expertise in both invasive laboratory cardiology, as well as echocardiography and nuclear cardiac imaging laboratories, and has served as director of both for many years.
For the past decade, Dr. Zuravicky has practiced an integrated approach to cardiovascular care, emphasizing both primary and secondary prevention, risk stratification combining multiple biomarkers assessment, and a variety of risk reduction management modalities.
Microbot Medical Ltd. is the first medical device company specializing in the research, design, development and commercialization of novel micro-robotics assisted medical technologies.http://www.microbotmedical.com
XACT Robotics Ltd. is developing a novel platform of robotic technology for needle steering in minimally invasive interventional procedures, based on 5 degrees-of-freedom, ongoing needle path calculation and real-time closed-loop control approach.http://www.xactrobotics.com
We invest in people. We believe in establishing long lasting relationships. It’s simple math: great people make successful companies. This is why at the core of our X Model that directs our business, you will find yourself in its center. It is also the reason we invest in students, researchers, physicians as well as entrepreneurs.
It’s you first, and we will aim to be there for continuous support. Let us know about your idea, company, or even if you face a problem that together we can explore a potential solution.
Tell us about your idea, let’s solve an unmet need together